News
COVID-19 may alter gut microbiota
January 29, 2021
Changes in gut microorganisms may contribute to severe disease and long-term symptoms after the virus clears.
![1]()
News
Anticoagulation and antiplatelet therapy after GI bleed cut mortality, ischemic events
January 28, 2021
In patients who present with a gastrointestinal bleed (GIB) while on an anticoagulants (AC) or antiplatelets (AP), what are the risks and benefits to resuming these medications?
News
Updated USPSTF HBV screening recommendation may be a ‘lost opportunity’
January 12, 2021
The recommendation defines risk groups more narrowly than the CDC, AASLD, and some research suggests risk-based screening is ineffective for chronic conditions.
News
Anorexia and diarrhea top list of GI symptoms in COVID-19 patients
December 30, 2020
Increased ALT levels were the most common sign of abnormal liver function in adults with severe COVID-19.
![1]()
News
COVID-19 vaccines: Safe for immunocompromised patients?
December 17, 2020
Data are limited thus far, and the safety and efficacy of the COVID-19 vaccines in immunocompromised patients remain unknown.
News
C. difficile control could require integrated approach
December 9, 2020
Australian researchers call for a One Health approach to limit spread.
News
Upper GI bleeds in COVID-19 not related to increased mortality
December 9, 2020
A Spanish survey suggests upper GI bleeding and delays in endoscopies in COVID-19 patients have little effect on in-hospital mortality.
News
Mortality higher in older adults hospitalized for IBD
December 4, 2020
Adults older than 65 years had significantly higher rates of inpatient IBD mortality than those under 65 years.
![1]()
News
Rationale for baricitinib’s use in COVID-19 patients demonstrated
November 24, 2020
“We went from modeling and mechanistic investigations to clinical tests in a number of settings and laboratory analysis in record time,” Dr. Justin Stebbing said.
News
Liver injury linked to COVID-19–related coagulopathy
November 18, 2020
Cells that line the liver’s blood vessels produce high levels of factor VIII, a coagulation factor, when they are exposed to interleukin-6, an inflammatory molecule associated with COVID-19.
